New Cancer Risk Tool That Flags Patients Early Seeks FDA Approval
Summary
A new medical device called C the Signs scans patient medical records to identify early signs of cancer risk without extra tests. The tool is being reviewed by the U.S. Food and Drug Administration (FDA) and is already used by the UK's National Health Service (NHS).Key Facts
- C the Signs analyzes medical histories quickly, spotting patterns that might indicate early cancer risk.
- It is designed to catch cancer risk earlier than traditional screening, potentially before obvious symptoms appear.
- Over 11,000 healthcare workers in the UK use the tool, which has helped detect cancer in 75,000 patients.
- The tool shortens the time to diagnose cancer by 21 percent in the UK.
- The FDA is reviewing the device, and the company plans to test it with 250,000 Americans this year.
- C the Signs has a 99% rate of correctly identifying patients who do not have cancer.
- It can predict the origin of tumors with 94% accuracy.
- The device uses separate models to screen for different types of cancer to improve accuracy.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.